Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Shannon, Leah"'
Autor:
Shannon, Leah, Cox, Sherry K., Bailey, Joan, Fortner, Chelsea, Davis, Rebecca, Gerhardt, Lillian, Souza, Marcy J.
Publikováno v:
Journal of Avian Medicine and Surgery, 2020 Mar 01. 34(1), 3-8.
Externí odkaz:
https://www.jstor.org/stable/48686307
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Academy of Management Proceedings. 2020:18330
Publikováno v:
Academy of Management Proceedings. 2018:17810
A field study was conducted to examine whether self-identified feminists experienced more discrimination (i.e., interpersonal and formal discrimination) than individuals appearing to advocate more ...
Autor:
Douglas B. Evans, Beth Erickson, Shannon Leah Schmidt, James P. Thomas, Paul S. Ritch, Vipal Durkal, Kathleen K. Christians, Ben George, Shinoj Pattali Jayavalsan, Susan Tsai
Publikováno v:
Journal of Clinical Oncology. 34:428-428
428 Background: FOLFIRINOX(FFX)/FOLFOX(FX) and Nab-paclitaxel plus Gemcitabine (NabG) represent standard first line (FL) treatment options for MPAC, but there is no prospective data to ascertain the ideal sequence of these regimens when used off prot
Autor:
Douglas B. Evans, Ben George, James P. Thomas, Vipal Durkal, Paul S. Ritch, Susan Tsai, Beth Erickson, Shannon Leah Schmidt, Kathleen K. Christians, Shinoj Pattali Jayavalsan
Publikováno v:
Journal of Clinical Oncology. 34:397-397
397 Background: Standard front line (FL) chemotherapy regimens for MPAC include FOLFIRINOX (FFX)/FOLFOX(FX) and Nab-paclitaxel plus Gemcitabine (NabG). Outcome data in patients treated with both FFX/FX and NabG has not been well characterized. We ret
Autor:
Ben George, Shannon Leah Schmidt, Vipal Durkal, Susan Tsai, Paul S. Ritch, Douglas B. Evans, Kathleen K. Christians, Shinoj Pattali Jayavalsan, Beth Erickson, James P. Thomas
Publikováno v:
Journal of Clinical Oncology. 34:443-443
443 Background: Front-line (FL) chemotherapy regimens for MPAC include FOLFIRINOX (FFX)/FOLFOX (FX) and Nab-paclitaxel plus Gemcitabine (NabG). We examined our hypothesis that objective response (OR) to these regimens can influence clinical outcome w
Autor:
Shannon Leah Schmidt, Paul E. Knudson, Mei-Jie Zhang, Timothy S. Fenske, Daniel Eastwood, Emily L. Richter, Linda S. Blust, Jeanne Palmer, Ehab Atallah
Publikováno v:
Blood. 120:4323-4323
Abstract 4323 Introduction: Hyperglycemia (HyG) has been shown to be detrimental in acute leukemia. In patients with acute myelogenous leukemia, hyG was associated with increased hospital mortality (Ali, et. al. Cancer 2007) while in patients with ac
Autor:
Schmidt, Shannon Leah *, Blust, Linda *, Knudson, Paul *, Richter, Emily *, Fenske, Timothy S., Palmer, Jeanne, Zhang, Mei-Jie *, Eastwood, Dan *, Atallah, Ehab *
Publikováno v:
In Blood 16 November 2012 120(21):4323-4323
Publikováno v:
Academy of Management Annual Meeting Proceedings. 2020, Vol. 2020 Issue 1, p1-1. 1p.